We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2001;161(4):501. doi:10.1001/archinte.161.4.501.
Text Size: A A A
Published online


Estrogen replacement lowers low-density lipoprotein cholesterol and raises high-density lipoprotein cholesterol in women with cardiovascular disease. The first 2 randomized trials of hormone replacement therapy showed no cardiovascular benefit in women. In contrast, randomized trials such as that of Welty suggest that statin drugs lower coronary disease risk equally well in women and men in both primary and secondary prevention.

See Article


The diagnosis of PAP is mainly based on histopathologic findings obtained with transbronchial lung biopsy (TBLB) or open lung biopsy specimens. However, the diagnostic yield of transbronchial lung biopsy is usually unsatisfactory. With the advent of improved bronchoscopic techniques, bronchoalveolar lavage (BAL) has proved to be valuable in providing a diagnosis of PAP; however, the ultrastructural examination of BAL fluid (BALF) specimens and/or specific stains are usually required. Clinically, it is impractical to process all routing specimens for electron microscopy or special stains. The findings of Chou et al suggest that globules stained green, orange, or orange in the center coated with a green rim as seen in Papanicolaou-stained smears of a BALF specimen can be of significant value in aiding the diagnosis of PAP.

See Article


Aspirin and angiotension-converting enzyme (ACE) inhibitors are strongly recommended for secondary prevention after acute myocardial (AMI), but several studies have suggested that the combination of these medications may produce a negative interaction. Krumholz et al evaluated the effect and interaction of aspirin and ACE inhibitors on mortality in patients older than 65 years who survived hospitalization at an acute care, nongovernmental hospital in the United States with a confirmed AMI from 1994 to 1995 and who were ideal candidates for the therapies. In the multivariate analysis, patients who received both aspirin and ACE inhibitors alone had a significantly lower 1-year mortality compared with patients who received neither aspirin nor ACE inhibitors at discharge. Prescribing both aspirin and ACE inhibitors was associated with a greater reduction in mortality than that seen in aspirin-only or ACE inhibitor-only groups, but the benefit was not significantly different in patients who used either medication alone. In conclusion, the benefit of ACE inhibitors and aspirin is consistent with what would be expected from overall results of randomized trials; prescribed together, the outcome is slightly better than with either medication alone, but not significantly so. This study generally supports current treatment guidelines and does not indicate that the combination of aspirin and ACE inhibitors is harmful to patients.

See Article


Many adolescents smoke to control their weight, but whether adults also smoke to control their weight is not known. Based on a national household survey of over 17 000 adults conducted in 1995, Wee and colleagues found that adults 30 years and older were actually as likely or less likely to smoke if they were also trying to lose weight. Young adults (aged 18 to 30 years), however, were more likely to smoke if they were trying to lose weight, even after adjusting for sociodemographic factors and body mass index. Nevertheless, smokers of all ages expressed a desire to quit smoking whether or not they were actively try to lose weight. The authors suggest that young adults may be smoking to control their weight, and recommend that health efforts should target them for education about smoking and healthy weight control methods. The authors also believe that health providers should not be deterred from having discussions about smoking and smoking cessation with those who are trying to lose weight.

See Article




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.